RXSTRxSight, Inc.

$313M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+71.5% YoY

Gross Profit

$3M34.0% margin

Operating Income

-$15M-174.0% margin

Net Income

-$16M-186.7% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

+45.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$193M

Total Liabilities

$54M

Stockholders' Equity

$138M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+71.5%
Gross Profit	$3M	$1M	+107.9%
Operating Income	-$15M	-$8M	-76.6%
Net Income	-$16M	$26M	-159.8%

Revenue Segments

L D D

$5M96%

Service Warranty Service Contracts And Accessories

$216,0004%

RXST Q4 2021 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena